Examining the effect of gene reduction in MIR-95 and enhanced radiosensitivity in non-small cell lung cancer

Cancer Gene Therapy

Volumn 23, Issue 2-3, 2016, Pages 66-71

  Ma, W ^a   Ma, C N ^a   Li, X D ^a   Zhang, Y J ^a  

^a HENAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 9; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; MICRORNA 126; MICRORNA 155; MICRORNA 181 3P; MICRORNA 200C; MICRORNA 24; MICRORNA 324; MICRORNA 328; MICRORNA 335; MICRORNA 483 3P; MICRORNA 505; MICRORNA 66; MICRORNA 7; MICRORNA 787; MICRORNA 95; MICRORNA LET 7G; PROTEIN BCL 2; UNCLASSIFIED DRUG; MIRN95 MICRORNA, HUMAN; TUMOR MARKER;

A549 CELL LINE; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; APOPTOSIS ASSAY; ARTICLE; CANCER GENE THERAPY; CANCER INHIBITION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RESISTANCE; CANCER TISSUE; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE REDUCTION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; IN VIVO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; MTT ASSAY; NON SMALL CELL LUNG CANCER; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIVITY; RAT; REAL TIME POLYMERASE CHAIN REACTION; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT; UPREGULATION; WESTERN BLOTTING; A-549 CELL LINE; ANIMAL; CARCINOMA, NON-SMALL-CELL LUNG; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; LUNG NEOPLASMS; METABOLISM; RADIATION TOLERANCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT;

A549 CELLS; ANIMALS; APOPTOSIS; BIOMARKERS, TUMOR; CARCINOMA, NON-SMALL-CELL LUNG; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; RADIATION TOLERANCE; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84959219166     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/cgt.2016.2     Document Type: Article

References (41)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T et al. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96.
2. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10-29.
3. Fidias P, Novello S. Strategies for prolonged therapy in patients with advanced non-small-cell lung cancer. J Clin Oncol 2010; 28: 5116-5123.
4. Fuld AD, Dragnev KH, Rigas JR. Pemetrexed in advanced non-small-cell lung cancer. Expert Opin Pharmacother 2010; 11: 1387-1402.
5. Whitehurst AW, Bodemann BO, Cardenas J, Ferguson D, Girard L, Peyton M et al. Sythetic lethal screen identification of chemosensitizer loci in cancer cells. Nature 2007; 446: 815-819.
6. le Péchoux C. Role of postoperative radiotherapy in resected non-small cell lung cancer: a reassessment based on new data. Oncologist 2011; 16: 672-681.
7. Danesi R, Pasqualetti G, Giovannetti E, Crea F, Altavilla G, Del Tacca M et al. Pharmacogenomics in non-small-cell lung cancer chemotherapy. Adv Drug Deliv Rev 2009; 61: 408-417.
8. Rödel F, Hoffmann J, Distel L, Herrmann M, Noisternig T, Papadopoulos T et al. Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer. Cancer Res 2005; 65: 4881-4887.
9. Lee S, Lim MJ, Kim MH, Yu CH, Yun YS, Ahn J et al. An effective strategy for increasing the radiosensitivity of Human lung Cancer cells by blocking Nrf2-dependent antioxidant responses. Free Radic Biol Med 2012; 53: 807-816.
10. Provencio M, Sánchez A, Garrido P, Valcárce F. New molecular targeted therapies integrated with radiation therapy in lung cancer. Clin Lung Cancer 2010; 11: 91-97.
11. Del Vescovo V, Grasso M, Barbareschi M, Denti MA. MicroRNAs as lung cancer biomarkers. World J Clin Oncol 2014; 5: 604-620.
12. Zhang Y, Yang Q, Wang S. MicroRNAs: a new key in lung cancer. Cancer Che-mother Pharmacol 2014; 74: 1105-1111.
13. Xu YM, Liao XY, Chen XW, Li DZ, Sun JG, Liao RX. Regulation of miRNAs affects radiobiological response of lung cancer stem cells. Biomed Res Int 2015; 2015: 851-841.
14. Cortez MA, Valdecanas D, Zhang X, Zhan Y, Bhardwaj V, Calin GA et al. Therapeutic delivery of miR-200c enhances radiosensitivity in lung cancer. Mol Ther 2014; 22: 1494-1503.
15. Korpela E, Vesprini D, Liu SK. MicroRNA in radiotherapy: miRage or miRador? Br J Cancer 2015; 112: 777-782.
16. Oh J-S, Kim J-J, Byun J-Y, Kim I-A. Lin28-let7 modulates radiosensitivity of human cancer cells with activation of K-ras. Int J Radiat Oncol Biol Phys 2010; 76: 5-8.
17. Salim H, Akbar NS, Zong D, Vaculova AH, Lewensohn R, Moshfegh A et al. miRNA-214 modulates radiotherapy response of non-small cell lung cancer cells through regulation of p38MAPK, apoptosis and senescence. Br J Cancer 2012; 107: 1361-1373.
18. Zhao Z, Zhang L, Yao Q, Tao Z. miR-15b regulates cisplatin resistance and metastasis by targeting PEBP4 in human lung adenocarcinoma cells. Cancer Gene Ther 2015; 22: 108-114.
19. Huang X, Taeb S, Jahangiri S, Emmenegger U, Tran E, Bruce J et al. miRNA-95 mediates radioresistance in tumours by targeting the sphingolipid phosphatase SGPP1. Cancer Res 2013; 73: 6972-6986.
20. Shen Z, Wu X, Wang Z, Li B, Zhu X. Effect of miR-18a overexpression on the radiosensitivity of non-small cell lung cancer. Int J Clin Exp Pathol 2015; 8: 643-648.
21. Babar IA, Czochor J, Steinmetz A, Weidhaas JB, Glazer PM, Slack FJ. Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells. Cancer Biol Ther 2011; 12: 908-914.
22. Ma Y, Xia H, Liu Y, Li M. Silencing miR-21 sensitizes non-small cell lung cancer A549 cells to ionizing radiation through inhibition of PI3K/Akt. Biomed Res Int 2014; 2014: 617868.
23. Shin S, Cha HJ, Lee EM, Lee SJ, Seo SK, Jin HO et al. Alteration of miRNA profiles by ionizing radiation in A549 human non-small cell lung cancer cells. Int J Oncol 2009; 35: 81-86.
24. Liu YJ, Lin YF, Chen YF, Luo EC, Sher YP, Tsai MH et al. MicroRNA-449a enhances radiosensitivity in CL1-0 lung adenocarcinoma cells. PLoS One 2013; 8: e62383.
25. Di Francesco A, de Pitta C, Moret F, Barbieri V, Celotti L, Mognato M. The DNA-damage response to gamma-radiation is affected by miR-27a in A549 cells. Int J Mol Sci 2013; 14: 17881-17896.
26. Weidhaas JB, Babar I, Nallur SM, Trang P, Roush S, Boehm M et al. MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy. Cancer Res 2007; 67: 11111-11116.
27. Arora H, Qureshi R, Jin S, Park AK, Park WY. miR-9 and let-7g enhance the sensitivity to ionizing radiation by suppression of NFkappaB1. Exp Mol Med 2011; 43: 298-304.
28. Wang XC, Du LQ, Tian LL, Wu HL, Jiang XY, Zhang H et al. Expression and function of miRNA in postoperative radiotherapy sensitive and resistant patients of non-small cell lung cancer. Lung Cancer 2011; 72: 92-99.
29. Ranade AR, Weiss GJ. Methods for microRNA microarray profiling. Methods Mol Biol 2011; 700: 145-152.
30. Schulze-Bergkamen H, Krammer PH. Apoptosis in cancer-implications for therapy. Semin Oncol 2004; 31: 90-119.
31. Mirkovic N, Voehringer DW, Story MD, McConkey DJ, McDonnell TJ, Meyn RE. Resistance to radiation-induced apoptosis in Bcl-2-expressing cells is reversed by depleting cellular thiols. Oncogene 1997; 15: 1461-1470.
32. Raffoul JJ, Wang Y, Kucuk O, Forman JD, Sarkar FH, Hillman GG. Genistein inhibits radiation-induced activation of NF-kappaB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest. BMC Cancer 2006; 6: 107.
33. Chen S, Wang H, Ng WL, Curran WJ, Wang Y. Radiosensitizing effects of ectopic miR-101 on non-small-cell lung cancer cells depend on the endogenous miR-101 level. Int J Radiat Oncol Biol Phys 2011; 81: 1524-1529.
34. Wu Y, Liu GL, Liu SH, Wang CX, Xu YL, Ying Y et al. MicroRNA-148b enhances the radiosensitivity of non-Hodgkin's Lymphoma cells by promoting radiation-induced apoptosis. J Radiat Res 2012; 53: 516-525.
35. Wang J, He J, Su F, Ding N, Hu W, Yao B et al. Repression of ATR pathway by miR-185 enhances radiation-induced apoptosis and proliferation inhibition. Cell Death Dis 2013; 4: e699.
36. Wang XC, Wang W, Zhang ZB, Zhao J, Tan XG, Luo JC. Overexpression of miRNA-21 promotes radiation-resistance of non-small cell lung cancer. Radiat Oncol 2013; 8: 146.
37. Chen X, Chen S, Hang W, Huang H, Ma H. MiR-95 induces proliferation and chemo-or radioresistance through directly targeting sorting nexin1 (SNX1) in non-small cell lung cancer. Biomed Pharmacother 2014; 68: 589-595.
38. Zhang J, Zhang C, Hu L, He Y, Shi Z, Tang S et al. Abnormal expression of miR-21 and miR-95 in cancer stem-like cells is associated with radioresistance of lung cancer. Cancer Invest 2015; 33: 165-171.
39. Huang Z, Huang S, Wang Q, Liang L, Ni S, Wang L et al. MicroRNA-95 promotes cell proliferation and targets sorting Nexin 1 in human colorectal carcinoma. Cancer Res 2011; 71: 2582-2589.
40. Hwang SJ, Lee HW, Kim HR, Song HJ, Lee DH, Lee H et al. Overexpression of microRNA-95-3p suppresses brain metastasis of lung adenocarcinoma through downregulation of cyclin D1. Oncotarget 2015; 6: 20434-20448.
41. Fan B, Jiao BH, Fan FS, Lu SK, Song J, Guo CY et al. Downregulation of miR-95-3p inhibits proliferation, and invasion promoting apoptosis of glioma cells by targeting CELF2. Int J Oncol 2015; 47: 1025-1033.